White House Council of Economic Advisors White Paper
On February 9, 2018 the White House Council of Economic Advisors issued a White Paper on “Reforming Biopharmaceutical Pricing at Home and Abroad.” The White Paper identified the 340B program…
President’s Budget Targets 340B / HHS Secretary Defends Budget Before Congress
President Trump’s 2019 budget request, released on February 12, 2018, included several provisions related to the 340B program. The proposed budget requires all 340B covered entities to report on use…
Update on 340B Ceiling Price and Manufacturer Civil Monetary Penalties
The White House Office of Management and Budget (OMB) has posted an abstract of HRSA’s new proposed rule on 340B Ceiling Price and Manufacturer Civil Monetary Penalties (CMP). The abstract…
Opioid Epidemic Declared Public Health Emergency – Implications for Ryan White Grantees
Last week, President Trump declared the opioid epidemic a national public health emergency. The declaration allows federal agencies “to use every appropriate emergency authority to fight the opioid crisis.” The…
340B Ceiling Price and Manufacturer CMP Rule
HRSA sent a new proposed rule on 340B Ceiling Price and Manufacturer Civil Monetary Penalties (CMPs) to the White House Office of Management and Budget (OMB) for review on October…
Tom Price Resigns as HHS Secretary
Tom Price announced his resignation as HHS Secretary on Friday amid criticism concerning his use of private jets funded by taxpayer dollars. The White House has named Don J. Wright,…
Draft Executive Order on Drug Prices
We received a copy of what we believe to be the Trump Administration’s draft executive order on drug prices that would direct HRSA to scale back the 340B Program. According…